As we report, for more‐expert diabetes practitioners, the NICE definition of MDI can be interpreted to include a person with T2D on any insulin therapy, including basal‐only insulin treatment split into two daily doses, basal insulin therapy requiring rescue injections with rapid‐acting insulin, and twice daily premixed insulin. This evidence concerns the gene INS and diabetes mellitus.